Ernexa Therapeutics Inc. · NASDAQ:ERNA
John D. Halpern reported a 5.60% stake in Ernexa Therapeutics Inc. (Schedule 13G/A)
Event Feb 10, 2026 · Filed May 15, 2026
John D. Halpern reported a 5.60% stake in Ernexa Therapeutics Inc., 66,751 shares, as a passive investor on Feb 10, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 5.60%
- Shares
- 66,751
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| John D. Halpern | 5.60% | 66,751 |
| Katherine H. Halpern | 5.60% | 66,751 |